SOW
OVID icon

State of Wyoming’s Ovid Therapeutics OVID Stock Holding History

State of Wyoming’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.2K Buy
+22,171
New +$39.6K 0.01% 1546
2023
Q3 		– Sell
-403
Closed -$1.32K – 1760
2023
Q2 		$1.32K Buy
403
+121
+43% +$411 ﹤0.01% 1511
2023
Q1 		$728 Sell
282
-11
-4% -$26 ﹤0.01% 1542
2022
Q4 		$545 Buy
293
+217
+286% +$370 ﹤0.01% 1523
2022
Q3 		$0 Buy
+76
New +$159 ﹤0.01% 1822

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State of Wyoming's OVID Position: Q1 2026 in Review

State of Wyoming opened a new position in Ovid Therapeutics (OVID) in Q1 2026: 22,171 shares worth $49.2K. The stake represents 0.01% of the portfolio and ranks #1546 among its holdings. This is a return to the name: State of Wyoming previously reported a position in OVID as recently as Q2 2023.

State of Wyoming first reported a position in OVID in Q3 2022 and has held it in 5 quarters since. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • State of Wyoming held 22,171 shares of Ovid Therapeutics worth $49.2K as of Q1 2026.
  • Ovid Therapeutics was a new State of Wyoming position in Q1 2026.
  • Ovid Therapeutics made up 0.01% of State of Wyoming's portfolio in Q1 2026, its #1546 holding.
  • State of Wyoming first reported a position in Ovid Therapeutics in Q3 2022 and has held it in 5 quarters since.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.